Carregant...
Clinical features of chronic hepatitis B patients with YMDD mutation after lamivudine therapy
Objective: To study the clinical features of chronic hepatitis B (CHB) patients with tyrosine-methionine-aspartate-aspartate (YMDD) mutation after lamivudine therapy. Methods: This investigation was a retrospective study of 63 CHB patients with YMDD mutation during lamivudine therapy. Clinical data,...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Zhejiang University Press
2005
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1390641/ https://ncbi.nlm.nih.gov/pubmed/16358376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1631/jzus.2005.B1182 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|